KR960703405A - 항-히스타민 및 항-알레르기 활성을 갖는 테트라졸 유도체(tetrazole derivatives having antihistaminic and antiallergic activity) - Google Patents

항-히스타민 및 항-알레르기 활성을 갖는 테트라졸 유도체(tetrazole derivatives having antihistaminic and antiallergic activity)

Info

Publication number
KR960703405A
KR960703405A KR1019950705952A KR19950705952A KR960703405A KR 960703405 A KR960703405 A KR 960703405A KR 1019950705952 A KR1019950705952 A KR 1019950705952A KR 19950705952 A KR19950705952 A KR 19950705952A KR 960703405 A KR960703405 A KR 960703405A
Authority
KR
South Korea
Prior art keywords
atom
bond
methine
integer
represent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019950705952A
Other languages
English (en)
Korean (ko)
Inventor
마사토시 하야시
마사야 가토
유스께 사까이
가즈히꼬 미쯔이
Original Assignee
나까무라 다메아끼
스미토모 긴조꾸 고우교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나까무라 다메아끼, 스미토모 긴조꾸 고우교 가부시끼가이샤 filed Critical 나까무라 다메아끼
Publication of KR960703405A publication Critical patent/KR960703405A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR1019950705952A 1993-06-29 1994-06-23 항-히스타민 및 항-알레르기 활성을 갖는 테트라졸 유도체(tetrazole derivatives having antihistaminic and antiallergic activity) Withdrawn KR960703405A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP15874193 1993-06-29
JP1993-158745 1993-06-29
JP1993-158741 1993-06-29
JP15874593 1993-06-29
JP13875694A JP3338913B2 (ja) 1993-06-29 1994-06-21 テトラゾール誘導体
JP1994-138756 1994-06-21
PCT/JP1994/001010 WO1995001350A1 (en) 1993-06-29 1994-06-23 Tetrazole derivatives having antihistaminic and antiallergic activity

Publications (1)

Publication Number Publication Date
KR960703405A true KR960703405A (ko) 1996-08-17

Family

ID=27317735

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950705952A Withdrawn KR960703405A (ko) 1993-06-29 1994-06-23 항-히스타민 및 항-알레르기 활성을 갖는 테트라졸 유도체(tetrazole derivatives having antihistaminic and antiallergic activity)

Country Status (8)

Country Link
EP (1) EP0706522A1 (enExample)
JP (1) JP3338913B2 (enExample)
KR (1) KR960703405A (enExample)
AU (1) AU673754B2 (enExample)
CA (1) CA2165792A1 (enExample)
IL (1) IL110144A0 (enExample)
TW (1) TW281677B (enExample)
WO (1) WO1995001350A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
EP0916668A4 (en) * 1996-07-29 2000-08-16 Banyu Pharma Co Ltd CHEMOKIN RECEPTOR ANTAGONISTS
ES2172436B1 (es) * 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
WO2003032912A2 (en) 2001-10-16 2003-04-24 Hypnion, Inc. Treatment of cns disorders using cns target modulators
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US7189757B2 (en) 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
AU2003296373A1 (en) * 2002-12-18 2004-07-29 Bayer Cropscience Ag N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
US7326721B2 (en) 2003-12-10 2008-02-05 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7411069B2 (en) 2003-12-10 2008-08-12 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7482460B2 (en) 2003-12-10 2009-01-27 Hypnion, Inc. Doxepin analogs and methods of use thereof
WO2005102335A2 (en) * 2004-04-23 2005-11-03 Hypnion, Inc. Methods of treating sleep disorders
US20080214570A1 (en) * 2005-08-08 2008-09-04 Astrazeneca Ab Therapeutic Agents
WO2010013805A1 (ja) * 2008-08-01 2010-02-04 日本臓器製薬株式会社 アミノプロピリデン誘導体
JP7040802B2 (ja) * 2017-06-30 2022-03-23 株式会社ニコン 光学装置を製造する方法及び対応するシステム
JP6991315B2 (ja) 2018-04-19 2022-01-12 国立大学法人東京農工大学 サルコペニアの予防剤及び治療剤
CN113880808B (zh) * 2020-07-03 2024-12-31 合肥医工医药股份有限公司 一类三唑类化合物、制备方法及其医药用途
EP4691466A1 (en) 2023-07-25 2026-02-11 The Eye Hospital of Wenzhou Medical University Use of ptgds inhibitor in preparation of drug for treating cataracts
CN117599052A (zh) * 2023-07-25 2024-02-27 温州医科大学附属眼视光医院 Ptgds的抑制剂在制备治疗白内障药物上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
JPH03246287A (ja) * 1990-02-22 1991-11-01 Hokuriku Seiyaku Co Ltd ピペラジン誘導体
FR2665160A1 (fr) * 1990-07-26 1992-01-31 Esteve Labor Dr Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments.
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
CA2165792A1 (en) 1995-01-12
AU673754B2 (en) 1996-11-21
JPH0770112A (ja) 1995-03-14
JP3338913B2 (ja) 2002-10-28
AU6983094A (en) 1995-01-24
IL110144A0 (en) 1994-10-07
TW281677B (enExample) 1996-07-21
EP0706522A1 (en) 1996-04-17
WO1995001350A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
KR960703405A (ko) 항-히스타민 및 항-알레르기 활성을 갖는 테트라졸 유도체(tetrazole derivatives having antihistaminic and antiallergic activity)
ATE448226T1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
DE60119397D1 (de) "2-Oxo-1-Pyrrolidinderivate und ihre pharmazeutische Verwendung"
BR0314761A (pt) Composto de adenina e seu uso
CA2167673A1 (en) Condensed benzazepine derivative and pharmaceutical composition thereof
NO972482D0 (no) Nytt amidinonafthylderivat eller salt derav
DK1074542T3 (da) Sulfonamidholdige indolforbindelser
DE60129697D1 (de) Kondensierte azepinderivate und ihre verwendung als als antidiuretisches mittel
KR900006342A (ko) 1,4-디아제핀 유도체 및 그의 약학적 이용
ATE416157T1 (de) Inhibitoren von integrin alpha-v-beta-6
KR960701878A (ko) 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents)
ES2165274B1 (es) Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
KR960007592A (ko) 신규한 피롤로카바졸
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
AR029343A1 (es) USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN
TW427979B (en) A condensed piperidine compound
KR890005088A (ko) 4- 아미노피리딘 유도체 및 그의 산 부가염
NO308532B1 (no) Farmasøytiske piperazinforbindelser
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
ATE170851T1 (de) Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten
DE69315363D1 (de) Amphotere tricyclische Verbindungen als antihistaminische und antiallergische Mittel
KR900009640A (ko) 벤족 사제핀 유도체
HUP9902270A1 (hu) Analgetikus hatású akridinszármazékok, előállításuk és alkalmazásuk
DE3762621D1 (de) Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung.

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000